BUILDING TRUST IN DIGITAL EDUCATION: TECHNICAL ARCHITECTURE AND STRATEGIC ADVANTAGES OF MFA IN MOBILE LEARNING PLATFORMS
Scientific bulletin · 2026-06 · 16 (2) · 284-292
DOI: 10.54414/fofb1380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific bulletin, online erschienen am 19.06.2026. Verfasst von Orkhan Vagif KAZIMOV.
Abstract (Originalsprache)
While the rapid integration of mobile technologies into the education sector has freed the learning process from the constraints of time and space, it has simultaneously created significant cybersecurity vulnerabilities. This article explores the mechanisms for implementing Multi-Factor Authentication (MFA) to protect user data and ensure academic integrity within mobile learning (mlearning) ecosystems. The research analyzes the integration architecture of MFA into cloud-based Learning Management Systems (LMS), the technical advantages of biometric identification methods, and the impact of this technology on student user experience (UX). The article emphasizes that MFA is not only a tool for protection against cyberattacks but also a strategic element that preserves the institutional reputation of educational entities in the era of digital transformation. Finally, the study proposes adaptive and user-friendly authentication models for mobile learning platforms.
Zitieren
APA
KAZIMOV, O. V. (2026). BUILDING TRUST IN DIGITAL EDUCATION: TECHNICAL ARCHITECTURE AND STRATEGIC ADVANTAGES OF MFA IN MOBILE LEARNING PLATFORMS. Scientific bulletin, 16(2), 284-292. https://doi.org/10.54414/fofb1380
Vancouver
KAZIMOV OV. BUILDING TRUST IN DIGITAL EDUCATION: TECHNICAL ARCHITECTURE AND STRATEGIC ADVANTAGES OF MFA IN MOBILE LEARNING PLATFORMS. Scientific bulletin. 2026;16(2):284-292. doi:10.54414/fofb1380
BibTeX
@article{KAZIMOV2026,
author = {KAZIMOV, Orkhan Vagif},
title = {BUILDING TRUST IN DIGITAL EDUCATION: TECHNICAL ARCHITECTURE AND STRATEGIC ADVANTAGES OF MFA IN MOBILE LEARNING PLATFORMS},
journal = {Scientific bulletin},
year = {2026},
volume = {16},
number = {2},
pages = {284--292},
doi = {10.54414/fofb1380}
}
EUVIMED